artesunic acid has been researched along with Rhabdomyosarcoma, Embryonal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beccafico, S; Donato, R; Marchetti, MC; Morozzi, G; Riccardi, C; Sidoni, A; Sorci, G | 1 |
1 other study(ies) available for artesunic acid and Rhabdomyosarcoma, Embryonal
Article | Year |
---|---|
Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Damage; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Integrin beta1; Mice; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; Neural Cell Adhesion Molecules; p38 Mitogen-Activated Protein Kinases; PAX7 Transcription Factor; Pyridines; Reactive Oxygen Species; Rhabdomyosarcoma, Embryonal; Transplantation, Heterologous | 2015 |